CASI Pharmaceuticals (CASIF) Inventory (2021 - 2025)

CASI Pharmaceuticals has reported Inventory for 5 years, with the latest figure at $1.6 million in Q4 2025.

• For the quarter ending Q4 2025, Inventory fell 69.57% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (down 69.57% YoY), and the FY2025 full-year result was $1.6 million, down 69.57% from the prior year.
• Inventory for Q4 2025 stood at $1.6 million, down from $2.6 million in the prior quarter.
• The five-year high for Inventory was $15.9 billion in Q4 2023, with the low at $1.6 million in Q4 2025.
• Historically, Inventory has averaged $3.9 billion across 5 years, with a median of $6.1 million in 2022.
• Annual changes were most pronounced in 2023 — Inventory jumped 258567.32% — and 2025, when it sank 99.98%.
• CASI Pharmaceuticals' Inventory stood at $1.9 million in 2021, then soared by 221.87% to $6.1 million in 2022, then jumped by 258567.32% to $15.9 billion in 2023, then slumped by 99.97% to $5.3 million in 2024, then sank by 69.57% to $1.6 million in 2025.
• The last three Inventory figures came in at $1.6 million (Q4 2025), $2.6 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.